Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-10-17
2006-10-17
O'Hara, Eileeen B. (Department: 1647)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023500, C530S350000
Reexamination Certificate
active
07122648
ABSTRACT:
The present invention provides for nucleic acid sequences that encode novel mammalian intracellular signaling polypeptides, designated MINC102. The invention also provides assay systems that may be used to detect and/or measure agents that bind the MINC102 gene product. The present invention also provides for diagnostic and therapeutic methods for treating muscle atrophy by inhibiting expression or activity of MINC102.
REFERENCES:
Bodine, et al, (2001) Science 294: 1704-1708.
Bodine, et al. 2001 Nature Cell Biology 3:1014-1019.
Rommel, et al (1999) Science 286: 1738-1741.
Coleman, et al. (1995) The Journal of Biological Chemistry 270: 12109-12116.
Rommel, et al. Nature (2001) 3: 1009-1013.
Gregg, Esq. Valeta
O'Hara Eileeen B.
Regeneron Pharmaceuticals Inc.
Wegert Sandra
LandOfFree
Ion channel receptor and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ion channel receptor and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ion channel receptor and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3632383